Sales & Marketing | pharmaphorum

News

Digital health firm Pear considers future as cash dwindles

Company looks at possible sale, merger or licensing deal after making big layoffs last year.

News

Chasing BMS, Takeda trumpets TYK2 data in psoriasis

Pharma group is hoping for big things, after splashing out $4bn upfront for the drug last year.

News

Sanofi cuts price of Lantus insulin in US by 78%

Pharma joins Eli Lilly, Novo Nordisk as it slashes the price of its widely-prescribed insulins.

News

Esperion and Daiichi Sankyo square up on Nexletol milestone

Companies can't see eye to eye on the recently reported data from the CLEAR outcomes study.

News

Novo Nordisk suspended from ABPI after code breach

The two-year ban reflects "serious breaches” of the trade organisation’s code of practice.

News

Changing Faces: Pharma-adjacent hires from February 2023

Combining an agency and consultancy roundup with a digital and supplier roundup.

Sales & Marketing

Sponsored

What it means to be the partner of choice in pharma

For both big pharma and small, partnership just makes sense.

News

US imposes first rebates on drugs with price hikes

Manufacturers will have to pay or face fines on drugs whose prices rose ahead of inflation.

News

Digital health firm Pear considers future as cash dwindles

Company looks at possible sale, merger or licensing deal after making big layoffs last year.

News

Chasing BMS, Takeda trumpets TYK2 data in psoriasis

Pharma group is hoping for big things, after splashing out $4bn upfront for the drug last year.

Press Releases

News

PM Society Awards - new category for 2023

PM Society Awards 17th March 2023 | JW Marriott Grosvenor House

Views & Analysis

Sales & Marketing

Sponsored

What it means to be the partner of choice in pharma

For both big pharma and small, partnership just makes sense.

Sales & Marketing

Navigating the virtual healthcare explosion with automation

For pharmaceutical companies, telehealth has become a significant funnel in its supply chain.

Deep Dive

Sales & Marketing

Deep Dive Frontiers Health 2022

20 – 21 October 2022 | MILAN & ONLINE

Sales & Marketing

Inside the colourful history of pharma advertising

Pharma companies employ a variety of tactics to increase brand awareness and promote their products.

Digital

The missing pieces of the digital therapeutics puzzle

When it comes to marketing digital therapeutics, companies can only do so much on their own until certain information infrastructure is in place, Kristin Milburn, managing director of Healt

Sales & Marketing

Sponsored

Partnering with NHS in a crisis: The role for industry

There has never been a better opportunity for the pharmaceutical industry for new partnerships

Sales & Marketing

Sponsored

How ‘thinking modular’ might ease digital content overload i...

Overview In today’s digital world it is increasingly hard for pharmaceutical companies to successfully differentiate new brands based on their target product profile alone.

Sales & Marketing

Sponsored

Applying behavioural interventions in chronic diseases

Overview Chronic diseases are the leading cause of death and disability worldwide and have a staggering impact on patients’ lives and the provision of healthcare around the world.

Podcasts

Sales & Marketing

Investing in healthcare futures: Elia Stupka and Paul Tunnah

Angelini Ventures is an new investment fund seeking companies transformational in healthcare.

Sales & Marketing

The scattered seeds of the beginnings of change - a pharmaph...

Speaking with Rob Verheul, CEO of Graphite Digital, at Anthropy 2022 at the Eden Project, pharmaphorum web editor Nicole Raleigh enjoyed a minute discussing the event and

Sales & Marketing

BMS’ Catherine Owen on pharma commercialisation: the pharmap...

Episode 42 of the pharmaphorum podcast heard from Catherine Owen, who’s senior vice president of major markets at Bristol Myers Squibb, about the future of pharma commercialisation and comm

White Papers

Sales & Marketing

Sponsored

Unlocking the full power of data for Pharma

The value of data has never been greater in healthcare.

White Papers

Sponsored

4 ways to embed data-driven best practice in pharma HCP comm...

Virtual communications between sales reps and HCPs jumped significantly during 2020, making it more important than ever for pharma companies to maintain up-to-date customer data. O

Debates & Insight

Sponsored

Optimising patient outcomes through physician education

Physician education is undergoing a massive change as the volume of advances in therapies and practices increases and the use of digital channels facilitates new forms of scientific exchange.&n

Debates & Insight

Sponsored

How to optimise pharma’s digital HCP engagement

Pharmaceutical companies face a ‘digital imperative’ to engage with healthcare professionals through their preferred mix of channels if they are to bridge the gap between the value a compan

Sales & Marketing

Sponsored

Good data supports pharma sales reps to drive lead generatio...

Allow pharma sales reps to focus on the job in hand by making sure they have access to up-to-date, clean, accurate data.

Sales & Marketing

Sponsored

An integrated CRM saves time, money and drives sales efficie...

Like most pharmaceutical companies, Théa Pharma places the utmost importance on quality customer data – but non-integrated systems were holding the team back.

Partner Content

Ensuring A Zero-Risk Data Privacy Environment When Capturing...

Capturing Medical Insights With Zero-Risk

Partner Content

Why Does Quant-Led KOL Identification Fail In Growth Markets...

When it comes to KOL identification mapping, there is no shortage of quant data around KOL and HCP activity out there.

Events

Partner Content

15th Annual Pre-Filled Syringes and Injectable Drug Devices ...

The Future of Drug Delivery and Combination Products

Digital health firm Pear considers future as cash dwindles

Chasing BMS, Takeda trumpets TYK2 data in psoriasis

Sanofi cuts price of Lantus insulin in US by 78%

Esperion and Daiichi Sankyo square up on Nexletol milestone

Novo Nordisk suspended from ABPI after code breach

Changing Faces: Pharma-adjacent hires from February 2023

What it means to be the partner of choice in pharma

US imposes first rebates on drugs with price hikes

Digital health firm Pear considers future as cash dwindles

Chasing BMS, Takeda trumpets TYK2 data in psoriasis

PM Society Awards - new category for 2023

What it means to be the partner of choice in pharma

Navigating the virtual healthcare explosion with automation

Deep Dive Frontiers Health 2022

Inside the colourful history of pharma advertising

The missing pieces of the digital therapeutics puzzle

Partnering with NHS in a crisis: The role for industry

How ‘thinking modular’ might ease digital content overload i...

Applying behavioural interventions in chronic diseases

Investing in healthcare futures: Elia Stupka and Paul Tunnah

The scattered seeds of the beginnings of change - a pharmaph...

BMS’ Catherine Owen on pharma commercialisation: the pharmap...

Unlocking the full power of data for Pharma

4 ways to embed data-driven best practice in pharma HCP comm...

Optimising patient outcomes through physician education

How to optimise pharma’s digital HCP engagement

Good data supports pharma sales reps to drive lead generatio...

An integrated CRM saves time, money and drives sales efficie...

Ensuring A Zero-Risk Data Privacy Environment When Capturing...

Why Does Quant-Led KOL Identification Fail In Growth Markets...

15th Annual Pre-Filled Syringes and Injectable Drug Devices ...

Could Daiichi Sankyo have another ADC winner in cancer?

An inside guide to unlocking clinical research in the UK

Others Old
-About pharmaphorum
-Articles
--eyeforpharma Barcelona 2015
-Audio
-barelonalive 2016
-Cancer
-Diabetes
--Diabetes
-Disease Spotlight
--DMD Main
--LHON Main
-ESMO2016
-ESMO2016-related
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-Featured content right column
-Featured Event
-Jobs
--pharmaphorum-live
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
-Podcast
-Premium media
-Quintiles
--Quintiles-oncol-PC
--Quintiles - ContentIO
--Quintiles - Articles
--Quintiles - Oncol articles
-Roundtables
--AZ-roundtable-biographies-2017
--AZ-roundtable-interviews-2017
--AZ-roundtable-debate-2017
-Sales and Marketing
--News
--Insights
--Appointments
--Debates
--Debates & Insight
--Views & Analysis
--Partner Content
-Slider in events
-Slider in home page
-Slider in video
-Slider in views and analysis
-Slider in webinars
-Slider in whitepapers
-Spotlight
--Understanding HCPs
--Future of Generics
--Frontiers Health 2022
--Frontiers Health 2021
--Behavioural Science
--ASCO 2019 Live coverage
--AI in Pharma Marketing
--ASCO 2019 and the future of oncology
-Startups
--Views & Analysis
--News
-System
-Top pharmaceutical companies
--Bristol-Myers Squibb
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--Merck Inc
--GlaxoSmithKline
--Gilead
--AstraZeneca
--AbbVie
-Top pharmaceutical companies
--Merck Inc
-Top stories
-Transversal Categories
--Brexit
--Clinical
--Digital and Social Media
--US
---Articles
--UK & Europe
--Sales and Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
--Healthcare
-Veeva
-Veeva channel content articles
-Veeva channel content webinars
-Video
-Views and analysis
-Webinars in home page
-Whitepapers
Others
-Transversal Categories
--Clinical
--Sustainability
--Brexit
--Digital and Social Media
--Healthcare
--US
--UK & Europe
--Sales & Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
-Top stories
-About pharmaphorum
-Top pharmaceutical companies
--Gilead
--Merck Inc
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--GlaxoSmithKline
--Bristol-Myers Squibb
--AstraZeneca
--AbbVie
-test webinar
-System
-Startups
--News
--Views & Analysis
-Veeva channel content webinars
-Webinars in home page
--Live webinar
--Webinars On demand
-Veeva channel content articles
-Veeva
-Spotlight
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-ESMO2016-related
-ESMO2016
-Featured Event
-Disease Spotlight
--LHON Main
--DMD Main
-Diabetes
--Diabetes
-Cancer
-barelonalive 2016
-Audio
-Articles
--eyeforpharma Barcelona 2015
-Slider in whitepapers
-Featured content right column
-Jobs
--pharmaphorum-live
-Roundtables
--AZ-roundtable-interviews-2017
--AZ-roundtable-biographies-2017
--AZ-roundtable-debate-2017
-Slider in webinars
-Slider in views and analysis
-Slider in video
-Slider in home page
-Slider in events
-Quintiles
--Quintiles-oncol-PC
--Quintiles - Oncol articles
--Quintiles - ContentIO
--Quintiles - Articles
-Premium media
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
Home
-News
-Views & Analysis
-Deep Dive
-Webinars
--Live webinar
-Podcasts
-Videos
-White Papers
-Events
--JP Morgan
--LSX Investech
--Anthropy
--Reuters Pharma 2022
--World Cancer Series
--Hlth 2022
--PM Society Awards
--Patient Summit PC
--Frontiers Health 2022
--FHlive17
--ASCO 2018
-Digital Debates
-Podcasts & Videos
-Partner Content
--Events
--News
--Appointments
--Press releases
Digital
-Appointments
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Market Access
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Oncology
-Appointments
-Debates
-Insights
-News
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Patients
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
R&D
-Appointments
-Debates
-Debates & Insights
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Partner Content
-Debates & Insight
Sales & Marketing
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Spotlight on
-AI in Pharma Marketing
-ASCO 2019 and the future of oncology
-ASCO 2019 Live coverage
-Behavioural Science
-Frontiers Health 2021
-Frontiers Health 2022
-Future of Generics
-Understanding HCPs
-The Future of Generics

News

Press Releases

Views & Analysis

Editor's Picks

Deep Dive

Webinars

Podcasts

White Papers

Debates & Insight

Partner Content

Editor's Picks